 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Institute for Tuberculosis Research, University of Illinois at Chicago |
| Street 1: | 833 S. Wood St. Rm 425, MC964 |
| Street 2: | MC 964 |
| City: | Chicago |
| Province: | IL |
| Post Code: | 60612-7231 |
| Country: | United States of America |
| Phone: | 13123551715 |
| Email: | sgf@uic.edu |
| Web Site: | http://tuberculosisdrugresearch.org |
|
|
||||||||||||||||||||||||||||
General Information | |
| Organization Type - Primary: | Academic / Research Institution |
| Organization Type - Secondary: | None |
| Is your organization legally registered in your country: | Yes |
| Organization Reach: | International |
| Organization Description: | |
| Research directed towards new drug discovery and development for tuberculosis. Also develop rapid, inexpensive, low tech assays for drug susceptibility testing. | |
| Total number of staff in your organization: | 11 - 25 |
| Number of full-time staff who are directly involved with TB: | 11 - 25 |
| Number of part-time staff who are directly involved with TB: | 1 - 5 |
| Number of volunteers who are directly involved with TB: | 0 |
| What is your organization's annual budget (USD) dedicated to TB? | $1 MIL-$10 MIL |
| How did you hear about the Stop TB Partnership: | Stop TB communications |
| Why do you wish join the Stop TB Partnership: | Involvement in Stop TB Working Groups |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | No |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| We are working to discovery new TB drugs that will shorten treatment duration. | |
Geographical Reach | |
| Which country is your headquarters located in: | United States of America |
| Which WHO region is the main focus of your work: | Global |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Brazil China Colombia Germany India Iran (Islamic Republic of) Italy Lao People's Democratic Republic Mexico Philippines Russian Federation South Africa Thailand United Kingdom of Great Britain and Northern Ireland United States of America Viet Nam |
Specializations | |
|
Research and Development |
Specializations in Countries | |
| Research and Development | Brazil |
| Research and Development | China |
| Research and Development | Colombia |
| Research and Development | Germany |
| Research and Development | India |
| Research and Development | Iran (Islamic Republic of) |
| Research and Development | Italy |
| Research and Development | Lao People's Democratic Republic |
| Research and Development | Mexico |
| Research and Development | Philippines |
| Research and Development | Russian Federation |
| Research and Development | South Africa |
| Research and Development | Thailand |
| Research and Development | United Kingdom of Great Britain and Northern Ireland |
| Research and Development | United States of America |
| Research and Development | Viet Nam |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
New TB Drugs: TB drug discovery including microbiology, natural products chemistry, medicinal chemistry, drug metabolism and pharmacokinetics. Fundamental Research: Evaluate new molecular targets and mechanisms of action of established and new candidate TB agents. |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | |
| Last updated: | May 15, 2012 |